Abigail Vanderheiden
Papers
1
Total Citations
8
H-Index
1
About
Abigail Vanderheiden is a prominent immunologist whose research focuses on the antibody response to emerging coronaviruses, particularly SARS-CoV-2. Her most cited work, "Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects" (2021, 8 citations), represents a key contribution to understanding how the human immune system can generate broadly neutralizing antibodies capable of targeting multiple coronavirus strains. This study isolated and characterized monoclonal antibodies from recovered COVID-19 patients, demonstrating their ability to cross-neutralize not only SARS-CoV-2 but also other related coronaviruses, offering critical insights for pan-coronavirus vaccine and therapeutic design. Vanderheiden’s work has helped illuminate the structural and functional basis of antibody-mediated neutralization, advancing the field’s capacity to prepare for future viral threats. Her research is highly regarded for its translational potential, bridging fundamental immunology with urgent public health needs. Through these contributions, Vanderheiden has established herself as a rising voice in infectious disease immunology, with her findings informing ongoing efforts to develop durable, broadly protective interventions against coronaviruses.
Research Focus
Key Achievements
Top Papers
- 1